Overview

Corporate Profile
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InFormTM), interactive response technology (ClarixTM), phase I clinic automation (LabPasTM), clinical data management (ClintrialTM), clinical trials signal detection (CTSDTM), strategic pharmacovigilance (Empiric... More >>
Stock Quote
PFWD (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$13.96
Change (%) Stock is Down 0.63 (4.32%)
Volume479,576
Data as of July 02, 2009 4:00 p.m.
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
Jun 30, 2009Phase Forward Customer GlaxoSmithKline Signs Multi-Year AgreementsPrinter Friendly Version
Jun 24, 2009Phase Forward's Russell J. Campanello Honored with STEVIE(R) Award for Human Resources Executive of the YearPrinter Friendly Version
Jun 23, 2009CORRECTING and REPLACING Phase Forward Customers Automate Adverse Event Reporting Management with Empirica(TM) TracePrinter Friendly Version
Jun 23, 2009Phase Forward Customers Automate Adverse Event Reporting Management with Empirica(TM) TracePrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Featured Report
Download Documentation 2008 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Phase Forward posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.